BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35988122)

  • 1. Management of perianal fistulas in Crohn's disease: a 2021 update of the French National Society of Coloproctology consensus.
    Bouchard D; Pigot F; de Parades V; Staumont G; Abramowitz L; Siproudhis L; ;
    Tech Coloproctol; 2022 Oct; 26(10):805-811. PubMed ID: 35988122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
    Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
    Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
    De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor SJ; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson AJ; Welman CJ; Yong EXZ; De Cruz P; van Langenberg D; Sparrow MP; Ding NS
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1306-1314. PubMed ID: 34389484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of anoperineal lesions in Crohn's disease: a French National Society of Coloproctology national consensus.
    Bouchard D; Pigot F; Staumont G; Siproudhis L; Abramowitz L; Benfredj P; Brochard C; Fathallah N; Faucheron JL; Higuero T; Panis Y; de Parades V; Vinson-Bonnet B; Laharie D
    Tech Coloproctol; 2018 Dec; 22(12):905-917. PubMed ID: 30604249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
    Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
    J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
    Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
    Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?
    Rinawi F; Greer MC; Walters T; Church PC; Ricciuto A; Langer JC; Griffiths AM
    J Pediatr Surg; 2022 Nov; 57(11):569-574. PubMed ID: 35491271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
    Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the modified Van Assche index for assessing response to anti-TNF therapy with MRI in perianal fistulizing Crohn's disease.
    van Rijn KL; Lansdorp CA; Tielbeek JAW; Nio CY; Buskens CJ; D'Haens GRAM; Löwenberg M; Stoker J
    Clin Imaging; 2020 Feb; 59(2):179-187. PubMed ID: 31821976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.
    Echarri A; Castro J; Barreiro M; Carpio D; Pereira S; Lorenzo A
    J Crohns Colitis; 2010 Dec; 4(6):654-60. PubMed ID: 21122576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    McCurdy JD; Parlow S; Dawkins Y; Samji K; Rhee GG; Oliveira L; Macdonald B; Sabri E; Murthy S
    Dig Dis Sci; 2020 Jun; 65(6):1784-1789. PubMed ID: 31642006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
    Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
    Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
    Papamichael K; Cheifetz AS
    World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study.
    Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Kwiecień J; Korczowski B; Maślana J
    Adv Clin Exp Med; 2016; 25(3):523-30. PubMed ID: 27629741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn's disease.
    Chambaz M; Verdalle-Cazes M; Desprez C; Thomassin L; Charpentier C; Grigioni S; Armengol-Debeir L; Bridoux V; Savoye G; Savoye-Collet C
    Dig Liver Dis; 2019 Mar; 51(3):358-363. PubMed ID: 30612820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep remission improves the quality of life of patients with Crohn's disease and anoperineal fistula treated with darvadstrocel: results of a French pilot study.
    Fathallah N; Akaffou M; Haouari MA; Spindler L; Alam A; Barré A; Pommaret E; Fels A; de Parades V
    Tech Coloproctol; 2023 Dec; 27(12):1201-1210. PubMed ID: 36811811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.